Compositions and methods for the treatment of fungal infections

US11446353B2 · kind B2 · utility

Assignees

• The Translational Genomics Research Institute · US
• Arizona Board of Regents on Behalf of Northern Arizona University · US

Inventors

• David Engelthaler · Flagstaff, US
• Elizabeth Driebe · Flagstaff, US
• Hongwei Yin · Scottsdale, US
• Michael Valentine · Flagstaff, US
• Donald Chow · Phoenix, US
• Jolene Bowers · Flagstaff, US
• Paul Keim · Flagstaff, US
• Bridget Barker · Flagstaff, US

Key dates

• Filing date: Jul 6, 2020
• Grant date: Sep 20, 2022
• Expiry date: Jul 6, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K45/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.